AGN 201904 [AGN-201904Z] versus esomeprazole in the prevention of aspirin-induced stomach or upper intestinal damage in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2011
At a glance
- Drugs AGN 201904Z; Esomeprazole
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- Sponsors Allergan
- 01 Jun 2011 Actual end date (Aug 2006) added as reported by ClinicalTrials.gov.
- 22 Mar 2008 New trial record.